Nonalcoholic Fatty Liver Disease in Lean Patients Linked With CVD Risk

Published May 14, 2022

MedPage Today reports on a study regarding nonalcoholic fatty liver disease in lean patients and how it’s linked with COVID-19 risk. “The results are interesting because the authors found a significantly increased prevalence of COVID compared to overweight/obese individuals even though the prevalence of risk factors for atherosclerotic disease and metabolic diseases were lower," said UB physician Andrew Talal, MD, MPH, who was not involved in the study.